Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.6%

1 terminated out of 18 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

22%

4 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed with results

Key Signals

1 with results90% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (7)
Early P 1 (1)
P 1 (1)
P 3 (1)
P 4 (3)

Trial Status

Completed9
Unknown5
Not Yet Recruiting3
Terminated1

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT04376567Not ApplicableTerminatedPrimary

Outcomes for One-stage and Two-stage Brachial Basilic Arteriovenous Fistulas

NCT07151664Not Yet Recruiting

Retrospective Analysis of Quality of Life Changes in Patients Undergoing Parathyroidectomy for End-Stage Renal Disease

NCT06389617Not ApplicableNot Yet RecruitingPrimary

Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block

NCT06378931Not Yet Recruiting

Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal Failure

NCT01834755Not ApplicableCompletedPrimary

Physical and Psychological Profiles Associated With Patient's Preference for ESRD Treatment

NCT01004627Not ApplicableCompletedPrimary

A Study of Routine Versus Selective Use of Ultrasound Scanning Prior to Haemodialysis Fistula Surgery

NCT01996930Phase 3Completed

Steroid Impregnated Tape in the Treatment of Over-granulating Peritoneal Dialysis Exit Sites

NCT02895425UnknownPrimary

Registry for End Stage Renal Failure

NCT01766882Not ApplicableCompletedPrimary

Volume,Sodium and Blood Pressure Management in HD

NCT02686398Phase 4Completed

Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis

NCT01781156UnknownPrimary

Effect of Reducing Phosphorus Absorption on Cardiac Biomarkers in Hemodialysis Patients

NCT02341547UnknownPrimary

Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'

NCT01990118Phase 4CompletedPrimary

Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients

NCT01906840Phase 1CompletedPrimary

Role of Turmeric on Oxidative Modulation in ESRD Patients

NCT01037595Early Phase 1CompletedPrimary

Effect of Turmeric on Pruritus in Hemodialysis Patients

NCT01704313Not ApplicableUnknownPrimary

A Trial of Interrupted vs Continuous Suturing Techniques for Radiocephalic Fistulae

NCT01704339Phase 4UnknownPrimary

Qutenza for Critical Ischaemia in End Stage Renal Failure

NCT01101217Not ApplicableCompletedPrimary

Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients

Showing all 18 trials

Research Network

Activity Timeline